Black Beetle Health’s Post

Inclusivity matters and this guide is a great resource! I am always open to learning more about my biases and how I can be more inclusive. I found the terminology portion of this to be helpful and suggest taking a look if you work in the breast/chest cancer space. Are you open to using transgender-inclusive terminology such as: Instead Of “Breast Cancer” Use “Breast/Chest Cancer." Instead Of “Breast Tissue” Use “Mammary Tissue.” Instead Of "Women” Use “Assigned Female At Birth.” Nobody should feel they need to avoid seeking out healthcare, including screenings, due to feelings of discrimination! https://lnkd.in/dm7h8E5y

Whitman-Walker's Jonathon Rendina, PhD, MPH and Dwight Venson joined Kim Thiboldeaux on GRAIL's #TheCancerSIGNAL #podcast to discuss how LGBTQ+ people and people of color face disparities in cancer incidence. Whitman-Walker, Cancer Support Community, and GRAIL are collaborating on INCLUDE, a study to evaluate multi-cancer early detection (MCED) testing’s impact within federally qualified health centers. The goal: make this kind of cancer screening available to more people in the future. Jon and Dwight discuss barriers to access, how LGTBQ+ and minority experiences of cancer care can be different, and how MCED testing may play a role in helping underserved groups. NOTE: Anyone living in the DC area who is interested in learning more about joining the INCLUDE study can reach out to: [email protected] LISTEN HERE: https://lnkd.in/gmcbsyPU #weseeyou #cancerresearch #whitmanwalker

Today marks the start of LGBTQ+ Pride Month. At Dana-Farber Cancer Institute we know that the LGBTQ+ community faces unique challenges when accessing comprehensive healthcare, and we work to provide care that addresses each person's cancer treatment in the context of their lives. Due to systemic discrimination, LGBTQ+ patients are at a higher risk for certain types of cancers. As one of the world's foremost cancer centers – and as a leader in providing equitable care and strong advocacy for LGBTQ+ patients – Dana-Farber is proud to serve patients of all genders and sexual orientations. We know that, like all of us, LGBTQ+ patients deserve the most innovative treatment available, as well as the special support their families and loved ones may need: o Our staff offers support groups for LGBTQ+ people who have been diagnosed with cancer. o Our clinical researchers offer unique clinical trials in the cancers to which LGBTQ+ patients are most at risk. o Our viral immunology researchers lead the field in HIV- and AIDS-related research breakthroughs. To learn more about Dana-Farber's commitment to LGBTQ+ patients and the programs we offer, visit: https://lnkd.in/ebavQbn4 #PrideMonth

Identifying Breast Cancer Symptoms: A Guide for the LGBTQ+ Community https://lnkd.in/e7HWCn5M The LGBTQ+ community faces unique challenges when it comes to breast cancer awareness and early detection. It’s crucial for individuals in this community to stay vigilant and familiarize themselves with the signs and symptoms of breast cancer, as early detection can significantly improve outcomes. Common Breast Cancer Symptoms to Watch For A lump, hard knot, or thickening in the breast or chest area Swelling, warmth, or redness in the breast or chest Changes in the size or shape of the breast or chest Dimpling or puckering of the skin An itchy, scaly rash on the breast or chest Nipple discharge or changes in the nipple’s appearance New pain in the breast, chest, or nipple area #breastcancerawareness #breastcancerprevention #feelitonthefirst #breastexams #pridemonth #gay #transgender #transgenderpride

Breast Cancer UK have an educational resource for transgender people to explain breast cancer risk🧡 Some topics covered include: - Hormones - Self-checking - Screening - High breast density Find it here 👉 https://bit.ly/3YGdMdH #breastcancer #LGBT #LGBTQ #health #support #cancer #transgender

#LGBTQI people should feel comfortable talking about their sexual identity, sexual behaviors, and/or gender identity when visiting a healthcare provider. For a list of affirming providers, check out our Queer Health is Power page: https://lnkd.in/erMZG92A. #QueerHealthIsPower #LGBTQHealth

Across the country, we’re working to increase access to quality, affordable care, eliminate cancer disparities, and break down barriers to proven cancer prevention and early detection tools for LGBTQ+ people. To support this work, ACS CAN commissioned the National LGBT Cancer Network to produce a report on the challenges faced by LGBTQ+ people impacted by cancer. ACS CAN’s LGBTQIA+ & Allies Engagement Group was also instrumental in informing these policy recommendations. Using these new recommendations, ACS CAN will continue our commitment to #HealthEquity by advancing public policies to eliminate barriers to #CancerCare for LGBTQ+ people. We will also continue to actively evaluate the impact of our engagement at both the federal and state levels on legislation that would prohibit discrimination based on sex, sexual orientation, and gender identity in employment, housing, public accommodations, education, and federally funded programs. #PrideMonth #CancerAdvocacy

#FoodForThoughtFriday: Lesbian, bisexual women and people assigned female at birth may be at increased risk for breast, cervical and ovarian cancer compared to heterosexual, cis-gendered women.    According to an existing body of research, lesbians, bisexual and transgender/nonbinary (TGNB) individuals are less likely to access preventive care than the general population due to multiple systemic factors including lower rates of insurance coverage, medical provider discrimination, and lack of provider knowledge of LGBTQ specific health care needs.    That’s why organizations like Callen-Lorde Community Health Center, a 2022 Prevent Cancer Foundation community grantee, are working to remove barriers and address gaps in care to improve access to culturally affirmative cervical cancer screening services. With their funding, Callen-Lorde implemented tailored provider and patient interventions designed to improve cancer screening uptake and adherence rates among lesbian, bisexual, transgender or gender non-binary (TGNB) individuals with a cervix living in New York City.     Referring to their awarded 2022 community grant project, Callen-Lorde shared, “We’ve thoroughly trained our providers on how to provide competent cervical cancer screenings and follow-up, we’ve created new workflows that ensure patients are notified of results in a timely manner and follow-up appointments are easier to schedule, and we’ve created surveillance reports that allow us to accurately track incidence in our patient population. Now that we’ve undertaken these improvements, we have the expertise to share with other organizations looking to provide sensitive, competent care to LGBTQ+ populations for cervical cancer screenings.”   We’re proud to support Callen-Lorde and their work providing needed services to the LGBTQ+ community. Learn more: https://bit.ly/3jqhxkb     #PrideMonth #LGBTQ #CancerPrevention #EarlyDetection #CommunityOutreach 

The authors of this preliminary study share that "Sexual orientation and gender identity data are not collected by most hospitals or cancer registries; thus, little is known about the quality of breast cancer treatment for patients from sex and gender minority (SGM) groups." It concludes that further study is needed. During #Pride month, and every month, we at the Coalition are here, now, to support and empower those in the LGBTQ+ community who are affected by #breastcancer or #GYNcancer. #survivorship #SurvivingandThriving https://lnkd.in/gnszATd7

Social Pharma Patient-Centric Marketing socialpharma.net >>> Gene&Cell Therapy >> Alnylam's big Phase 3 win; LGBTQ+ leaders charting paths; Chevron overturned; and more #lucidquest #genetherapy #celltherapy